Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04111458
Title A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | DEU

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Universitätsklinikum Frankfurt Frankfurt am Main 60590 Germany Details
Universitätsklinikum Köln (AöR) Köln 50937 Germany Details
Erasmus Medisch Centrum Rotterdam 3015 GD Netherlands Details
Universitair Medisch Centrum Utrecht Utrecht 3584 CX Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field